W-Z Biotech LLC Profile last edited on: 1/17/2024
CAGE: 5SDY5
UEI: RK1ZDCXE3LJ7
Business Identifier: Novel medical devices for cardiopulmonary surgery and hyperthermia delivery systems for lung cancer therapy 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 06
County: Fayette
Congr. District: 06
County: Fayette
Public Profile
Despite two increments of funding for the firm's Phase II project initiated in 2016, Google indicates the firm as being permanently closed. The firm had been developing a percutaneous double lumen cannula (DLC) for cavopulmonary assistance
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2024 | 2 | NIH | $1,505,230 | |
| Project Title: Development of a Minimally Invasive Single Cannulation, Compact Single Port Pulsatile Ventricular Assist Device (sppVAD) for Total LV Support | ||||
| 2023 | 1 | NIH | $275,355 | |
| Project Title: Pediatric Transapical Double Lumen Cannula with Integrated Compliance Chambers Doubles Flow of Paracorporeal Pulsatile VAD | ||||
| 2023 | 1 | NIH | $295,923 | |
| Project Title: Integration of Compliance Chambers into Diaphragm Displacement Pump to Double the Pumping Flow of Pediatric Paracorporeal Pulsatile Ventricular Assist Device | ||||
| 2019 | 2 | NIH | $1,646,010 | |
| Project Title: Development of Transapical to Aorta Double Lumen Cannula for a Neonate LVAD | ||||
| 2018 | 1 | NIH | $224,991 | |
| Project Title: Development of a Percutaneous Pulmonary Artery Drainage Device to Unload LV During VA Ecmo Support for Severe Cardiogenic Shock | ||||
Key People / Management
Dongfang Wang -- President, Co-Founder
Bill Sidor
Stephen R Topaz
Jay Zwischenberger -- Co-Founder
Bill Sidor
Stephen R Topaz
Jay Zwischenberger -- Co-Founder
Company News
There are no news available.
